Literature DB >> 10490108

Androgen metabolism in sebaceous glands from subjects with and without acne.

D Thiboutot1, K Gilliland, J Light, D Lookingbill.   

Abstract

OBJECTIVE: To determine if there are differences in the activity of 17beta-hydroxysteroid dehydrogenase and 5alpha-reductase (responsible for the production of testosterone and dihydrotestosterone, respectively) in sebaceous glands obtained from men and women with and without acne.
DESIGN: Single-center examination of androgen levels and sebaceous gland enzyme activity in a cohort of volunteers.
SETTING: Academic referral center. PATIENTS: Thirty-four subjects, consisting of 8 women with acne, 10 women without acne, 8 men with acne, and 8 men without acne.
INTERVENTIONS: Single visit for blood sampling and 2 biopsies of forehead skin. MAIN OUTCOME MEASURES: Serum levels of androgens were determined and compared with the activity of 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase in sebaceous glands microdissected from skin samples.
RESULTS: No significant differences in the activity of 5alpha-reductase or 17beta-hydroxysteroid dehydrogenase in sebaceous glands according to the presence of acne were noted in either men or women. The activity of 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase was significantly greater in sebaceous glands from men (n = 16) than women (n = 17). The oxidative activity of 17beta-hydroxysteroid dehydrogenase was 2-fold higher in men than women. Serum levels of dehydroepiandrosterone sulfate, androstenedione, testosterone, and dihydrotestosterone were significantly higher in women with acne than in women without acne. No differences in serum androgen levels were noted in men on the basis of the presence of acne.
CONCLUSIONS: Higher serum androgen levels are associated with the presence of acne in women. A role for locally produced androgens in this process, however, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490108     DOI: 10.1001/archderm.135.9.1041

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

2.  Examining the use of oral contraceptives in the management of acne.

Authors:  Heather L Salvaggio; Andrea L Zaenglein
Journal:  Int J Womens Health       Date:  2010-08-09

3.  [Acne tarda. Acne in adults].

Authors:  T Jansen; O E Janßen; G Plewig
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

4.  Effect of the glycemic index of carbohydrates on Acne vulgaris.

Authors:  Rebecca C Reynolds; Stephen Lee; James Y J Choi; Fiona S Atkinson; Karola S Stockmann; Peter Petocz; Jennie C Brand-Miller
Journal:  Nutrients       Date:  2010-10-18       Impact factor: 5.717

Review 5.  Adult-onset acne: prevalence, impact, and management challenges.

Authors:  Marco A Rocha; Ediléia Bagatin
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-02-01

6.  ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne.

Authors:  Marco Rocha; Karina H M Cardozo; Valdemir M Carvalho; Edieia Bagatin
Journal:  Dermatoendocrinol       Date:  2017-10-13

7.  Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.

Authors:  Enrico Carmina; Brigitte Dreno; W Anne Lucky; W George Agak; Anuja Dokras; Jin Ju Kim; Rogerio A Lobo; Fahimeh Ramezani Tehrani; Daniel Dumesic
Journal:  J Endocr Soc       Date:  2022-02-06

8.  Antiandrogenic Therapy with Ciproterone Acetate in Female Patients Who Suffer from Both Androgenetic Alopecia and Acne Vulgaris.

Authors:  Andrei Coneac; Adriana Muresan; Meda Sandra Orasan
Journal:  Clujul Med       Date:  2014-11-12

Review 9.  Dermatological problems of the puberty.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.